- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic lymphocytic leukaemia (CLL)
- Meeting Date: July 2020
- Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF 1115KB)
- Public Summary Document (PSD) July 2020 PBAC Meeting - (Word 95KB)
Venetoclax – July 2020
Venetoclax: Pack containing 14 tablets venetoclax 10 mg and 7 tablets venetoclax 50 mg and 7 tablets venetoclax 100 mg and 14 tablets venetoclax 100 mg, Tablet 10 mg, Tablet 50 mg, Tablet 100 mg; Venclexta®
Last updated
30 October 2020